AbCellera Biologics(ABCL) - 2023 Q4 - Earnings Call Transcript

AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2023 Results Conference Call February 20, 2024 5:00 PM ET Company Participants Tryn Stimart - Chief Legal & Compliance Officer Carl Hansen - President, CEO Andrew Booth - CFO Conference Call Participants Robyn Karnauskas - Truist Andrea Tan - Goldman Sachs Allison Bratzel - Piper Sandler Stephen Willey - Stifel Steven Mah - Cowen Evan Seigerman - BMO Operator Good afternoon. Thank you for attending AbCellera Biologics Inc. FY 2023 Earnings Results and Business Updat ...